Watts VJ - Search Results

1

LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors.

Watts VJ, Lawler CP, Fox DR, Neve KA, Nichols DE, Mailman RB. Watts VJ, et al. Psychopharmacology (Berl). 1995 Apr;118(4):401-9. doi: 10.1007/BF02245940. Psychopharmacology (Berl). 1995. PMID: 7568626

2

"Full" dopamine D1 agonists in human caudate: biochemical properties and therapeutic implications.

Gilmore JH, Watts VJ, Lawler CP, Noll EP, Nichols DE, Mailman RB. Gilmore JH, et al. Among authors: watts vj. Neuropharmacology. 1995 May;34(5):481-8. doi: 10.1016/0028-3908(95)00014-w. Neuropharmacology. 1995. PMID: 7566481

3

Dopamine D1 receptors: efficacy of full (dihydrexidine) vs. partial (SKF38393) agonists in primates vs. rodents.

Watts VJ, Lawler CP, Gilmore JH, Southerland SB, Nichols DE, Mailman RB. Watts VJ, et al. Eur J Pharmacol. 1993 Sep 28;242(2):165-72. doi: 10.1016/0014-2999(93)90076-t. Eur J Pharmacol. 1993. PMID: 7902811

4

Synthesis and molecular modeling of 1-phenyl-1,2,3,4-tetrahydroisoquinolines and related 5,6,8,9-tetrahydro-13bH-dibenzo[a,h]quinolizines as D1 dopamine antagonists.

Minor DL, Wyrick SD, Charifson PS, Watts VJ, Nichols DE, Mailman RB. Minor DL, et al. Among authors: watts vj. J Med Chem. 1994 Dec 9;37(25):4317-28. doi: 10.1021/jm00051a008. J Med Chem. 1994. PMID: 7996543

5

Hexahydrobenzo[a]phenanthridines: novel dopamine D3 receptor ligands.

Watts VJ, Lawler CP, Knoerzer T, Mayleben MA, Neve KA, Nichols DE, Mailman RB. Watts VJ, et al. Eur J Pharmacol. 1993 Aug 3;239(1-3):271-3. doi: 10.1016/0014-2999(93)91012-c. Eur J Pharmacol. 1993. PMID: 8223910

6

Conformational analysis of D1 dopamine receptor agonists: pharmacophore assessment and receptor mapping.

Mottola DM, Laiter S, Watts VJ, Tropsha A, Wyrick SD, Nichols DE, Mailman RB. Mottola DM, et al. Among authors: watts vj. J Med Chem. 1996 Jan 5;39(1):285-96. doi: 10.1021/jm9502100. J Med Chem. 1996. PMID: 8568818

7

Spare receptors and intrinsic activity: studies with D1 dopamine receptor agonists.

Watts VJ, Lawler CP, Gonzales AJ, Zhou QY, Civelli O, Nichols DE, Mailman RB. Watts VJ, et al. Synapse. 1995 Oct;21(2):177-87. doi: 10.1002/syn.890210211. Synapse. 1995. PMID: 8584979

8

Interhemispheric modulation of dopamine receptor interactions in unilateral 6-OHDA rodent model.

Lawler CP, Gilmore JH, Watts VJ, Walker QD, Southerland SB, Cook LL, Mathis CA, Mailman RB. Lawler CP, et al. Among authors: watts vj. Synapse. 1995 Dec;21(4):299-311. doi: 10.1002/syn.890210404. Synapse. 1995. PMID: 8869160

9

Homologous desensitization of the D1A dopamine receptor: efficacy in causing desensitization dissociates from both receptor occupancy and functional potency.

Lewis MM, Watts VJ, Lawler CP, Nichols DE, Mailman RB. Lewis MM, et al. Among authors: watts vj. J Pharmacol Exp Ther. 1998 Jul;286(1):345-53. J Pharmacol Exp Ther. 1998. PMID: 9655879

10

WAY-100635 is a potent dopamine D4 receptor agonist.

Chemel BR, Roth BL, Armbruster B, Watts VJ, Nichols DE. Chemel BR, et al. Among authors: watts vj. Psychopharmacology (Berl). 2006 Oct;188(2):244-51. doi: 10.1007/s00213-006-0490-4. Epub 2006 Aug 17. Psychopharmacology (Berl). 2006. PMID: 16915381

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters